To confirm that the HER2 status can be determined by Raman spectroscopy,we extended the list of studied cancer breast cell lines to the normalcells (MCF-10A) and triple-negative aggressive breast cancer (MDA-MB-231). Here, ERBB2 is linked to breast carcinoma.